Acta Neuropathologica, ISSN 0001-6322, 6/2013, Volume 125, Issue 6, pp. 777 - 794
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the aggregation of ubiquitinated proteins in affected motor neurons. Recent...
Aggregation | Pathology | Neurosciences | Protein degradation | Medicine & Public Health | Amyotrophic lateral sclerosis (ALS) | RNA granule | Motor neuron | RNA-PROCESSING PROTEIN | PRION-LIKE DOMAINS | PATHOLOGY | FRONTOTEMPORAL LOBAR DEGENERATION | DNA-BINDING PROTEIN | LENGTH POLYGLUTAMINE EXPANSIONS | NEUROSCIENCES | CLINICAL NEUROLOGY | NEURON DISEASES ALS | SPINAL MUSCULAR-ATROPHY | HEXANUCLEOTIDE REPEAT | C-TERMINAL FRAGMENTS | TRANSGENIC MICE | Transcription Factor TFIIIA - physiology | Proteins - physiology | DNA-Binding Proteins - physiology | Nerve Tissue Proteins - physiology | Humans | Inclusion Bodies - physiology | Ubiquitins - physiology | Amyotrophic Lateral Sclerosis - pathology | Ataxins | Proteolysis | Amyotrophic Lateral Sclerosis - metabolism | RNA-Binding Protein FUS - physiology | C9orf72 Protein | Amyotrophic Lateral Sclerosis - etiology | Cell Cycle Proteins - physiology | Review
Aggregation | Pathology | Neurosciences | Protein degradation | Medicine & Public Health | Amyotrophic lateral sclerosis (ALS) | RNA granule | Motor neuron | RNA-PROCESSING PROTEIN | PRION-LIKE DOMAINS | PATHOLOGY | FRONTOTEMPORAL LOBAR DEGENERATION | DNA-BINDING PROTEIN | LENGTH POLYGLUTAMINE EXPANSIONS | NEUROSCIENCES | CLINICAL NEUROLOGY | NEURON DISEASES ALS | SPINAL MUSCULAR-ATROPHY | HEXANUCLEOTIDE REPEAT | C-TERMINAL FRAGMENTS | TRANSGENIC MICE | Transcription Factor TFIIIA - physiology | Proteins - physiology | DNA-Binding Proteins - physiology | Nerve Tissue Proteins - physiology | Humans | Inclusion Bodies - physiology | Ubiquitins - physiology | Amyotrophic Lateral Sclerosis - pathology | Ataxins | Proteolysis | Amyotrophic Lateral Sclerosis - metabolism | RNA-Binding Protein FUS - physiology | C9orf72 Protein | Amyotrophic Lateral Sclerosis - etiology | Cell Cycle Proteins - physiology | Review
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2012, Volume 287, Issue 23, pp. 19440 - 19451
Aggregation of the microtubule associated protein Tau is associated with several neurodegenerative disorders, including Alzheimer disease and frontotemporal...
NEUROFIBRILLARY TANGLES | CELLS | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALPHA-SYNUCLEIN | PATHOLOGY | POLYGLUTAMINE AGGREGATION | NEURODEGENERATIVE DISEASES | PASSIVE-IMMUNIZATION | TANGLE MOUSE MODEL | PARKINSONS-DISEASE | Frontotemporal Dementia - genetics | Humans | tau Proteins - metabolism | Antibodies, Neutralizing - pharmacology | Multiprotein Complexes - genetics | Protein Folding | Alzheimer Disease - pathology | Multiprotein Complexes - antagonists & inhibitors | Frontotemporal Dementia - metabolism | Multiprotein Complexes - metabolism | tau Proteins - genetics | Models, Biological | Alzheimer Disease - metabolism | HEK293 Cells | Alzheimer Disease - genetics | Antibodies, Monoclonal, Murine-Derived - pharmacology | tau Proteins - antagonists & inhibitors | Frontotemporal Dementia - pathology | Aggregation | Aggregates | Propagation | Neurodegeneration | Fibrils | Neurobiology | Tau | Fluorescence Resonance Energy Transfer (FRET) | Alzheimer Disease
NEUROFIBRILLARY TANGLES | CELLS | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALPHA-SYNUCLEIN | PATHOLOGY | POLYGLUTAMINE AGGREGATION | NEURODEGENERATIVE DISEASES | PASSIVE-IMMUNIZATION | TANGLE MOUSE MODEL | PARKINSONS-DISEASE | Frontotemporal Dementia - genetics | Humans | tau Proteins - metabolism | Antibodies, Neutralizing - pharmacology | Multiprotein Complexes - genetics | Protein Folding | Alzheimer Disease - pathology | Multiprotein Complexes - antagonists & inhibitors | Frontotemporal Dementia - metabolism | Multiprotein Complexes - metabolism | tau Proteins - genetics | Models, Biological | Alzheimer Disease - metabolism | HEK293 Cells | Alzheimer Disease - genetics | Antibodies, Monoclonal, Murine-Derived - pharmacology | tau Proteins - antagonists & inhibitors | Frontotemporal Dementia - pathology | Aggregation | Aggregates | Propagation | Neurodegeneration | Fibrils | Neurobiology | Tau | Fluorescence Resonance Energy Transfer (FRET) | Alzheimer Disease
Journal Article
Journal of Molecular Biology, ISSN 0022-2836, 08/2012, Volume 421, Issue 2-3, pp. 160 - 171
The ability to relate bulk experimental measurements of amyloid formation to the microscopic assembly processes that underlie protein aggregation is critical...
nucleation | aggregation | amyloid | kinetics | mechanism | SPONTANEOUS FRAGMENTATION | NUCLEATED POLYMERIZATION | PRION DISEASES | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | AMYLOID-BETA-PROTEIN | ACTIN-FILAMENTS | POLYGLUTAMINE AGGREGATION | MISFOLDING DISEASES | ASSOCIATION | Models, Theoretical | Protein Binding | Proteins - metabolism | Kinetics | Amyloid - biosynthesis
nucleation | aggregation | amyloid | kinetics | mechanism | SPONTANEOUS FRAGMENTATION | NUCLEATED POLYMERIZATION | PRION DISEASES | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | AMYLOID-BETA-PROTEIN | ACTIN-FILAMENTS | POLYGLUTAMINE AGGREGATION | MISFOLDING DISEASES | ASSOCIATION | Models, Theoretical | Protein Binding | Proteins - metabolism | Kinetics | Amyloid - biosynthesis
Journal Article
Nature, ISSN 0028-0836, 12/2011, Volume 480, Issue 7378, pp. 543 - 546
Machado-Joseph disease (MJD; also called spinocerebellar ataxia type 3) is a dominantly inherited late-onset neurodegenerative disorder caused by expansion of...
POLYGLUTAMINE-EXPANDED ATAXIN-3 | IN-VITRO | INCLUSIONS | MULTIDISCIPLINARY SCIENCES | EXPANSION | NEURODEGENERATION | DISORDERS | MODEL | PROTEOLYSIS | CLEAVAGE | PROTEINS | Calpain - metabolism | Ataxin-3 | Glutamic Acid - pharmacology | Calcium - metabolism | Excitatory Amino Acids - pharmacology | Humans | Cells, Cultured | Nuclear Proteins - metabolism | Nerve Tissue Proteins - metabolism | Neurons - metabolism | Neurons - drug effects | Repressor Proteins - metabolism | Machado-Joseph Disease - pathology | Physiological aspects | Genetic engineering | Research | Cerebellar ataxia
POLYGLUTAMINE-EXPANDED ATAXIN-3 | IN-VITRO | INCLUSIONS | MULTIDISCIPLINARY SCIENCES | EXPANSION | NEURODEGENERATION | DISORDERS | MODEL | PROTEOLYSIS | CLEAVAGE | PROTEINS | Calpain - metabolism | Ataxin-3 | Glutamic Acid - pharmacology | Calcium - metabolism | Excitatory Amino Acids - pharmacology | Humans | Cells, Cultured | Nuclear Proteins - metabolism | Nerve Tissue Proteins - metabolism | Neurons - metabolism | Neurons - drug effects | Repressor Proteins - metabolism | Machado-Joseph Disease - pathology | Physiological aspects | Genetic engineering | Research | Cerebellar ataxia
Journal Article
Movement Disorders, ISSN 0885-3185, 2010, Volume 25, Issue S1, pp. S49 - S54
The cellular surveillance systems guarantee proper removal of altered components from inside cells. Alterations of these systems in neurons have been proposed...
neurodegeneration | lysosomes | protein aggregates | autophagy | proteases | Lysosomes | Neurodegeneration | Proteases | Autophagy | Protein aggregates | SYSTEM | CHAPERONE-MEDIATED AUTOPHAGY | SYNPHILIN-1 | ALPHA-SYNUCLEIN | CLINICAL NEUROLOGY | UBIQUITINATION | POLYGLUTAMINE DISEASES | PROTEASOME | BODY FORMATION | PARKINSONS-DISEASE | Neurons - pathology | Parkinson Disease - pathology | Humans | Ubiquitin - metabolism | Models, Molecular | Autophagy - physiology | Protein Folding | Animals | Proteins - metabolism | Protein Conformation | Neurons - metabolism | Parkinson Disease - metabolism | Proteasome Endopeptidase Complex - metabolism | alpha-Synuclein - metabolism
neurodegeneration | lysosomes | protein aggregates | autophagy | proteases | Lysosomes | Neurodegeneration | Proteases | Autophagy | Protein aggregates | SYSTEM | CHAPERONE-MEDIATED AUTOPHAGY | SYNPHILIN-1 | ALPHA-SYNUCLEIN | CLINICAL NEUROLOGY | UBIQUITINATION | POLYGLUTAMINE DISEASES | PROTEASOME | BODY FORMATION | PARKINSONS-DISEASE | Neurons - pathology | Parkinson Disease - pathology | Humans | Ubiquitin - metabolism | Models, Molecular | Autophagy - physiology | Protein Folding | Animals | Proteins - metabolism | Protein Conformation | Neurons - metabolism | Parkinson Disease - metabolism | Proteasome Endopeptidase Complex - metabolism | alpha-Synuclein - metabolism
Journal Article
Nature Structural & Molecular Biology, ISSN 1545-9993, 03/2011, Volume 18, Issue 3, pp. 328 - 336
Because polyglutamine (polyQ) aggregate formation has been implicated as playing an important role in expanded CAG repeat diseases, it is important to...
MECHANISM | PROTEIN AGGREGATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOMERIC POLYGLUTAMINE | CELL BIOLOGY | PRION PROTEIN | IN-VITRO | THERMODYNAMICS | PEPTIDES | BIOPHYSICS | AMYLOID FIBRIL ELONGATION | NUCLEATION | MOLECULAR-DYNAMICS SIMULATIONS | Peptides - metabolism | Kinetics | Neurodegenerative Diseases - metabolism | Protein Structure, Secondary | Humans | Physiological aspects | Nervous system diseases | Genetic aspects | Polypeptides | Research | Polymerization | Biophysics | Peptides | Molecular biology | Pathogenesis
MECHANISM | PROTEIN AGGREGATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOMERIC POLYGLUTAMINE | CELL BIOLOGY | PRION PROTEIN | IN-VITRO | THERMODYNAMICS | PEPTIDES | BIOPHYSICS | AMYLOID FIBRIL ELONGATION | NUCLEATION | MOLECULAR-DYNAMICS SIMULATIONS | Peptides - metabolism | Kinetics | Neurodegenerative Diseases - metabolism | Protein Structure, Secondary | Humans | Physiological aspects | Nervous system diseases | Genetic aspects | Polypeptides | Research | Polymerization | Biophysics | Peptides | Molecular biology | Pathogenesis
Journal Article
Brain Research, ISSN 0006-8993, 2013, Volume 1542, pp. 186 - 194
Abstract Protein aggregation is observed in various neurodegeneration diseases, including Parkinson's disease (PD). Alpha-synuclein, a causative gene product...
Neurology | α-Synuclein | Prefoldin | Protein aggregation | Cell death | Chaperone | UBIQUITIN-PROTEASOME SYSTEM | PROTEIN | HSP70 | MOLECULAR CHAPERONES | AUTOPHAGY | NEUROSCIENCES | POLYGLUTAMINE TOXICITY | OLIGOMERS | IN-VIVO | MUTATION | alpha-Synuclein | PARKINSONS-DISEASE | Green Fluorescent Proteins - metabolism | Molecular Chaperones - metabolism | Humans | RNA, Small Interfering - pharmacology | Molecular Chaperones - genetics | Ubiquitin - metabolism | Green Fluorescent Proteins - genetics | Mutation - genetics | Transfection | Cell Death - genetics | Cell Line, Tumor | Luminescent Proteins - genetics | alpha-Synuclein - genetics | Cell Death - drug effects | alpha-Synuclein - metabolism | Neuroblastoma - pathology | Luminescent Proteins - metabolism
Neurology | α-Synuclein | Prefoldin | Protein aggregation | Cell death | Chaperone | UBIQUITIN-PROTEASOME SYSTEM | PROTEIN | HSP70 | MOLECULAR CHAPERONES | AUTOPHAGY | NEUROSCIENCES | POLYGLUTAMINE TOXICITY | OLIGOMERS | IN-VIVO | MUTATION | alpha-Synuclein | PARKINSONS-DISEASE | Green Fluorescent Proteins - metabolism | Molecular Chaperones - metabolism | Humans | RNA, Small Interfering - pharmacology | Molecular Chaperones - genetics | Ubiquitin - metabolism | Green Fluorescent Proteins - genetics | Mutation - genetics | Transfection | Cell Death - genetics | Cell Line, Tumor | Luminescent Proteins - genetics | alpha-Synuclein - genetics | Cell Death - drug effects | alpha-Synuclein - metabolism | Neuroblastoma - pathology | Luminescent Proteins - metabolism
Journal Article
ACS Applied Materials and Interfaces, ISSN 1944-8244, 07/2017, Volume 9, Issue 28, pp. 24126 - 24139
Prevention and therapeutic strategies for various neurodegenerative diseases focus on inhibiting protein fibrillation, clearing aggregated protein plaques from...
neurodegenerative disease | nanoparticle | trehalose | amyloid aggregation | polyglutamine aggregation | Huntington's disease | Alzheimer's disease | BETA-PROTEIN FIBRILLATION | ALZHEIMERS-DISEASE | STABILITY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | NEUROTOXICITY | PEPTIDE | OLIGOMERS | INHIBITION | CHAPERONES | NUCLEATION | Huntington Disease | Nanoparticles | Animals | Peptides | Trehalose | Mice | Nerve Tissue Proteins | Index Medicus
neurodegenerative disease | nanoparticle | trehalose | amyloid aggregation | polyglutamine aggregation | Huntington's disease | Alzheimer's disease | BETA-PROTEIN FIBRILLATION | ALZHEIMERS-DISEASE | STABILITY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | NEUROTOXICITY | PEPTIDE | OLIGOMERS | INHIBITION | CHAPERONES | NUCLEATION | Huntington Disease | Nanoparticles | Animals | Peptides | Trehalose | Mice | Nerve Tissue Proteins | Index Medicus
Journal Article
The FEBS Journal, ISSN 1742-464X, 05/2018, Volume 285, Issue 10, pp. 1791 - 1811
Proteolytic cleavage of huntingtin gives rise to N‐terminal fragments. While the role of truncated mutant huntingtin is described in Huntington's disease (HD)...
amphipathic helix | N17 domain | holdase | huntingtin | yeast model | Amino Acid Sequence | Exons | Humans | Solubility | Huntingtin Protein - physiology | Green Fluorescent Proteins - genetics | Protein Aggregation, Pathological | Huntingtin Protein - chemistry | Particle Size | Sequence Homology, Amino Acid | Peptides - metabolism | Mutagenesis | Models, Biological | Proteolysis | Hydrophobic and Hydrophilic Interactions | Protein Conformation | Huntingtin Protein - genetics | Protein Stability | Tumor proteins | Cellular proteins | Polyglutamine | Yeast | Huntingtin | Pathogenesis | p53 Protein | Heat shock proteins | Agglomeration | Small heat shock proteins | Gene deletion | Synuclein | Huntington's disease | Proteins | Clonal deletion | Deletion | Polyproline | Protein interaction | Trinucleotide repeat diseases | Protein structure | Elongation | Heat shock
amphipathic helix | N17 domain | holdase | huntingtin | yeast model | Amino Acid Sequence | Exons | Humans | Solubility | Huntingtin Protein - physiology | Green Fluorescent Proteins - genetics | Protein Aggregation, Pathological | Huntingtin Protein - chemistry | Particle Size | Sequence Homology, Amino Acid | Peptides - metabolism | Mutagenesis | Models, Biological | Proteolysis | Hydrophobic and Hydrophilic Interactions | Protein Conformation | Huntingtin Protein - genetics | Protein Stability | Tumor proteins | Cellular proteins | Polyglutamine | Yeast | Huntingtin | Pathogenesis | p53 Protein | Heat shock proteins | Agglomeration | Small heat shock proteins | Gene deletion | Synuclein | Huntington's disease | Proteins | Clonal deletion | Deletion | Polyproline | Protein interaction | Trinucleotide repeat diseases | Protein structure | Elongation | Heat shock
Journal Article
The Lancet, ISSN 0140-6736, 05/2003, Volume 361, Issue 9369, pp. 1642 - 1644
Context Huntington's disease is a late onset neurodegenerative disorder for which the mutation is a CAG/polyglutamine (polyQ) repeat expansion in the gene...
NEURONAL INTRANUCLEAR INCLUSIONS | PATHOGENESIS | MEDICINE, GENERAL & INTERNAL | PEPTIDES | MECHANISM | CHANNELS | POLYGLUTAMINE AGGREGATION | BRAIN | Peptides - physiology | Humans | Peptides - genetics | Huntington Disease - genetics | Huntington Disease - metabolism | Cell Aggregation - genetics | Huntington Disease - etiology | Toxicity | Neurological disorders | Mutation | Huntingtons disease | Phenotypes | Huntingtin | Peptides | Pathogenesis | Huntington's disease | Proteins | Aggregates | Neurodegeneration | Toxic diseases | Localization | Apoptosis
NEURONAL INTRANUCLEAR INCLUSIONS | PATHOGENESIS | MEDICINE, GENERAL & INTERNAL | PEPTIDES | MECHANISM | CHANNELS | POLYGLUTAMINE AGGREGATION | BRAIN | Peptides - physiology | Humans | Peptides - genetics | Huntington Disease - genetics | Huntington Disease - metabolism | Cell Aggregation - genetics | Huntington Disease - etiology | Toxicity | Neurological disorders | Mutation | Huntingtons disease | Phenotypes | Huntingtin | Peptides | Pathogenesis | Huntington's disease | Proteins | Aggregates | Neurodegeneration | Toxic diseases | Localization | Apoptosis
Journal Article
Nature Reviews Molecular Cell Biology, ISSN 1471-0072, 11/2005, Volume 6, Issue 11, pp. 891 - 898
Journal Article